Affirm makes the math work for more budgets
Current clinical evidence suggests tirzepatide should be discontinued at least 2 months before attempting conception, though individual timelines depend on your health profile and treatment goals
Response to electroconvulsive therapy in bipolar depression The effect of electroconvulsive therapy (ECT) on bipolar depression has not been investigated in RCTs, and the maintenance effect is controversial, with potential side effects including cognitive effects
The overarching issue is that compounded medications are not FDA-approved, which means their safety, efficacy, and quality are less predictable, says Dr
Ipamorelin, the first selective growth hormone secretagogue Raun K, Hansen BS, Johansen NL, et al